X. Li

690 total citations
21 papers, 503 citations indexed

About

X. Li is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, X. Li has authored 21 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in X. Li's work include Genomics, phytochemicals, and oxidative stress (2 papers), Diabetes Management and Research (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). X. Li is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (2 papers), Diabetes Management and Research (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). X. Li collaborates with scholars based in China, United States and South Korea. X. Li's co-authors include Zhengdong Huang, Guangcun He, Hongbo Pan, Hao Yang, Zhonghai Li, H. Wang, Jianru Wang, Haoran Liu, Zhaomin Zheng and Zuojun Hu and has published in prestigious journals such as ACS Nano, Biomaterials and ACS Applied Materials & Interfaces.

In The Last Decade

X. Li

19 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
X. Li China 9 163 125 88 85 72 21 503
Xinglong Liu China 15 49 0.3× 147 1.2× 86 1.0× 15 0.2× 29 0.4× 43 465
Santanu Rana India 11 19 0.1× 171 1.4× 61 0.7× 83 1.0× 13 0.2× 14 371
Xiaohong Zheng China 11 58 0.4× 276 2.2× 19 0.2× 30 0.4× 72 1.0× 31 547
Jatindra Nath Mohanty India 9 160 1.0× 118 0.9× 26 0.3× 13 0.2× 17 0.2× 49 396
Hongli Xu China 15 98 0.6× 169 1.4× 70 0.8× 9 0.1× 40 0.6× 40 475
Hongjie Liang China 15 202 1.2× 194 1.6× 25 0.3× 20 0.2× 14 0.2× 45 598
Iwona Niedzielska Poland 15 45 0.3× 98 0.8× 34 0.4× 135 1.6× 63 0.9× 67 617
R.J. Bosch Spain 11 25 0.2× 67 0.5× 26 0.3× 54 0.6× 47 0.7× 33 593
Yasuo Matsuzawa Japan 15 324 2.0× 370 3.0× 51 0.6× 4 0.0× 134 1.9× 76 781
Rongya Yang China 12 27 0.2× 143 1.1× 15 0.2× 7 0.1× 57 0.8× 39 493

Countries citing papers authored by X. Li

Since Specialization
Citations

This map shows the geographic impact of X. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Li more than expected).

Fields of papers citing papers by X. Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Li. The network helps show where X. Li may publish in the future.

Co-authorship network of co-authors of X. Li

This figure shows the co-authorship network connecting the top 25 collaborators of X. Li. A scholar is included among the top collaborators of X. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with X. Li. X. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Xiaomin, Yue Liu, Jiayi Wu, et al.. (2025). An omics-based drug-HIFU combination therapy discovery for ferroptosis treatment of TNBC. Biomaterials. 324. 123535–123535.
3.
Li, X., Takuji Yamaguchi, Masashi Tabuchi, et al.. (2025). Protective Effects of Centella asiatica Against Senescence and Apoptosis in Epidermal Cells. Biology. 14(2). 202–202. 2 indexed citations
4.
Wang, Yangfeng, Jinglai Duan, Z. Q. Zhu, et al.. (2025). Electrolyte Solvation Structure Regulation for Low-Temperature Sodium-Ion Battery. ACS Applied Materials & Interfaces. 17(21). 30885–30894. 5 indexed citations
6.
Li, X., et al.. (2024). Shionone Relieves Ulcerative Colitis by Regulating the p38 MAPK/NF-κB Pathway. Revista Brasileira de Farmacognosia. 34(5). 1071–1078. 1 indexed citations
7.
Xiao, Li, et al.. (2022). POS-342 ATF5 INVOLVES IN TUBULOINTERSTITIAL INJURY OF DIABETIC KIDNEY DISEASE VIA REGULATING THE UPRmt PATHWAY. Kidney International Reports. 7(2). S155–S155. 2 indexed citations
8.
Li, X., et al.. (2020). Methylation of PAX1 Gene Promoter in the Prediction of Concurrent Chemo-radiotherapy Efficacy in Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. 108(3). e461–e461. 1 indexed citations
9.
Dai, Yingbo, X. Li, Ke Cao, et al.. (2017). Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway. Cell Death and Disease. 8(3). e2691–e2691. 32 indexed citations
10.
Li, Zhonghai, Hongbo Pan, Hao Yang, et al.. (2016). Resistin promotes CCL4 expression through toll-like receptor-4 and activation of the p38-MAPK and NF-κB signaling pathways: implications for intervertebral disc degeneration. Osteoarthritis and Cartilage. 25(2). 341–350. 91 indexed citations
11.
Li, X., et al.. (2016). The polymorphichMSH5C85T allele augments radiotherapy-induced spermatogenic impairment. Andrology. 4(5). 873–879. 5 indexed citations
12.
Li, X., et al.. (2016). Prognostic effect of high-flux hemodialysis in patients with chronic kidney disease. Brazilian Journal of Medical and Biological Research. 49(1). e4708–e4708. 10 indexed citations
13.
Li, X., et al.. (2014). Tumor necrosis factor receptor-II nt587 polymorphism in Chinese Han patients with ankylosing spondylitis. Genetics and Molecular Research. 13(3). 5190–5198. 1 indexed citations
14.
Li, X., Z. Li, Weibin Zhou, et al.. (2013). Overexpression of 4EBP1, p70S6K, Akt1 or Akt2 differentially promotes Coxsackievirus B3-induced apoptosis in HeLa cells. Cell Death and Disease. 4(9). e803–e803. 21 indexed citations
15.
Hu, Zuojun, et al.. (2011). Endovascular Stent-graft Treatment for Stanford Type A Aortic Dissection. European Journal of Vascular and Endovascular Surgery. 42(6). 787–794. 53 indexed citations
16.
Shu, Chang, et al.. (2010). Endovascular Percutaneous Treatment of Tuberculous Pseudo-aneurysm Involving the Coeliac Artery: A Case Report. European Journal of Vascular and Endovascular Surgery. 40(2). 230–233. 6 indexed citations
17.
Liu, Wei, Lei Chen, Hongtao Duan, et al.. (2009). Novel CTX-M  -lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China. Journal of Antimicrobial Chemotherapy. 63(5). 895–900. 57 indexed citations
18.
Li, X., et al.. (2004). Optimal Cutoff Point of Glutamate Decarboxylase Antibody Titers in Differentiating Two Subtypes of Adult‐Onset Latent Autoimmune Diabetes. Annals of the New York Academy of Sciences. 1037(1). 122–126. 21 indexed citations
19.
Huang, Zhengdong, et al.. (2001). Identification and mapping of two brown planthopper resistance genes in rice. Theoretical and Applied Genetics. 102(6-7). 929–934. 174 indexed citations
20.
Li, X., Michael Jaye, Gregg Crumley, & Ethylin Wang Jabs. (1992). Dinucleotide repeat polymorphism in the human fibroblast growth factor acidic (FGFA) gene on chromosome 5. Human Molecular Genetics. 1(3). 216–216. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026